West Pharmaceutical Services, Inc. (NYSE:WST) Receives $350.00 Average Price Target from Brokerages

West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five ratings firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month […]

Related Keywords

United States ,America ,Quintinj Lai ,Asia Pacific ,Charles Witherspoon ,Altshuler Shaham Ltd ,First Horizon Advisors Inc ,Analyst Recommendations For West Pharmaceutical Services ,Raleigh Capital Management Inc ,Services Inc ,Keycorp ,News Ratings For West Pharmaceutical Services Daily ,Services Stock Down ,Securities Exchange Commission ,Sunbelt Securities Inc ,West Pharmaceutical Services ,Get Free Report ,Marketbeat Ratings ,Pharmaceutical Services Stock Down ,Pharmaceutical Services ,Exchange Commission ,Capital Management ,Shaham Ltd ,Street Markets ,First Horizon Advisors ,Horizon Advisors ,Get Free ,Middle East ,Proprietary Products ,West Pharmaceutical Services Daily ,Nyse Wst ,Wst ,Medical ,95530610 ,Ratings ,Consensus ,